Department of Medicine, Harvard Medical School, Boston, Mass; Division of Rheumatology, Immunology, and Allergy, Jeff and Penny Vinik Center for Allergic Disease Research, Brigham and Women's Hospital, Boston, Mass.
Division of Rheumatology, Immunology, and Allergy, Jeff and Penny Vinik Center for Allergic Disease Research, Brigham and Women's Hospital, Boston, Mass.
J Allergy Clin Immunol. 2014 Jun;133(6):1692-701.e3. doi: 10.1016/j.jaci.2013.12.1034. Epub 2014 Jan 31.
Aspirin-exacerbated respiratory disease (AERD) is an inflammatory condition of the respiratory tract and is characterized by overproduction of leukotrienes (LT) and large numbers of circulating granulocyte-platelet complexes. LT production can be suppressed by prostaglandin E(2) (PGE(2)) and the cyclic AMP-dependent protein kinase A (PKA).
To determine if PGE(2)-dependent control of LT production by granulocytes is dysregulated in AERD.
Granulocytes from well-characterized patients with and without AERD were activated ex vivo and subjected to a range of functional and biochemical analyses.
Granulocytes from subjects with AERD generated more LTB4 and cysteinyl LTs than did granulocytes from controls with aspirin-tolerant asthma and controls without asthma. When compared with controls, granulocytes from subjects with AERD had comparable levels of EP(2) protein expression and PGE(2)-mediated cAMP accumulation, yet were resistant to PGE(2)-mediated suppression of LT generation. Percentages of platelet-adherent neutrophils correlated positively with LTB4 generation and inversely with responsiveness to PGE(2)-mediated suppression of LTB(4). The PKA inhibitor H89 potentiated LTB4 generation by control granulocytes but was inactive in granulocytes from individuals with AERD and had no effect on platelet P-selectin induction. Both tonic PKA activity and levels of PKA catalytic gamma subunit protein were significantly lower in granulocytes from individuals with AERD relative to those from controls.
Impaired granulocyte PKA function in AERD may lead to dysregulated control of 5-lipoxygenase activity by PGE(2), whereas adherent platelets lead to increased production of LTs, which contributes to the features of persistent respiratory tract inflammation and LT overproduction.
阿司匹林加重性呼吸系统疾病(AERD)是一种呼吸道炎症性疾病,其特征是白三烯(LT)过度产生和循环中大量粒细胞-血小板复合物。前列腺素 E(2)(PGE(2))和环磷酸腺苷依赖性蛋白激酶 A(PKA)可以抑制 LT 的产生。
确定 AERD 中粒细胞中 PGE(2)依赖性 LT 产生的控制是否失调。
对来自 AERD 患者和非 AERD 患者的成熟粒细胞进行体外激活,并进行一系列功能和生化分析。
与阿司匹林耐受型哮喘和非哮喘对照组的粒细胞相比,AERD 患者的粒细胞产生的 LTB4 和半胱氨酰 LT 更多。与对照组相比,AERD 患者的粒细胞具有相似的 EP(2)蛋白表达水平和 PGE(2)介导的 cAMP 积累,但对 PGE(2)介导的 LT 生成抑制具有抗性。血小板黏附的中性粒细胞百分比与 LTB4 的产生呈正相关,与对 PGE(2)介导的抑制 LTB(4)的反应呈负相关。PKA 抑制剂 H89 增强了对照组粒细胞中 LTB4 的产生,但在 AERD 患者的粒细胞中无活性,对血小板 P-选择素诱导也没有影响。与对照组相比,AERD 患者的粒细胞中 PKA 活性和 PKA 催化γ亚基蛋白水平均明显降低。
AERD 中粒细胞 PKA 功能受损可能导致 PGE(2)对 5-脂氧合酶活性的控制失调,而黏附的血小板导致 LT 的产生增加,这有助于持续性呼吸道炎症和 LT 过度产生的特征。